Isolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors
Marco Inserra(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands)), Paul F. Alewood(The University of Queensland), Shiva N. Kompella(RMIT University), Andreas Brust(The University of Queensland), David J. Craik(The University of Queensland), Norelle L. Daly(Australian Institute of Tropical Health and Medicine), Irina Vetter(Centre National de la Recherche Scientifique), Hartmut Cuny(RMIT University), David J. Adams(University of Wollongong)
Cited by 53
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422